Hims & Hers Health (XSWX:HIMS) Marketable Securities: CHF528.61 Mil (As of Mar. 2026)


XSWX:HIMS Hims & Hers Health Inc XSWX:HIMS
81 GF Score
Price CHF29.90
GF Value CHF32.30
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Marketable Securities?

Hims & Hers Health XSWX:HIMS 81 Marketable Securities is CHF528.61 Mil as of Mar. 2026. GuruFocus rates XSWX:HIMS with a GF Score™ of 81/100 and a GF Value™ of CHF32.30. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Hims & Hers Health's Marketable Securities for the quarter that ended in Mar. 2026 was CHF528.61 Mil.

Hims & Hers Health's annual Marketable Securities declined from Dec. 2023 (CHF124.32 Mil) to Dec. 2024 (CHF79.67 Mil) but then increased from Dec. 2024 (CHF79.67 Mil) to Dec. 2025 (CHF348.88 Mil).

Hims & Hers Health  (XSWX:HIMS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Hims & Hers Health Marketable Securities Related Terms

Hims & Hers Health Marketable Securities Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Marketable Securities Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 175.49 132.85 124.32 79.67 348.88

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.94 20.03 283.97 348.88 528.61
XSWX:HIMS
81GF Score
Hims & Hers Health Inc XSWX:HIMS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of CHF528.61 Mil mean?
Hims & Hers Health (XSWX:HIMS) has a Marketable Securities of CHF528.61 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Marketable Securities too high?
Hims & Hers Health's current Marketable Securities is CHF528.61 Mil. Overall, Hims & Hers Health has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Marketable Securities compare to ?
Hims & Hers Health's Marketable Securities of CHF528.61 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Marketable Securities is CHF528.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Hims & Hers Health (XSWX:HIMS) has a current Marketable Securities of CHF528.61 Mil. The stock's GF Value™ is CHF32.30, compared to a current price of CHF29.90 — trading 7.4% below its estimated fair value. The current Marketable Securities is CHF528.61 Mil. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Hims & Hers Health (XSWX:HIMS), the current Marketable Securities is CHF528.61 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of CHF29.90 is trading 7.4% below its estimated GF Value™ of CHF32.30.

Key valuation signals for XSWX:HIMS:

  • Marketable Securities: CHF528.61 Mil
  • GF Value™: CHF32.30 vs. price of CHF29.90 (7.4% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Comparable Companies
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score

Get the complete analysis for XSWX:HIMS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF29.90
Price
CHF32.30
GF Value